MilliporeSigma
  • Home
  • Search Results
  • SIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies.

SIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies.

Bioorganic & medicinal chemistry (2012-11-20)
G Vaidyanathan, B J White, D J Affleck, X G Zhao, P C Welsh, D McDougald, J Choi, M R Zalutsky
ABSTRACT

A major drawback of internalizing monoclonal antibodies (mAbs) radioiodinated with direct electrophilic approaches is that tumor retention of radioactivity is compromised by the rapid washout of iodo-tyrosine, the primary labeled catabolite for mAbs labeled via this strategy. In our continuing efforts to develop more versatile residualizing labels that could overcome this problem, we have designed SIB-DOTA, a prosthetic labeling template that combines the features of the prototypical, dehalogenation-resistant N-succinimidyl 3-iodobenzoate (SIB) with DOTA, a useful macrocyclic chelator for labeling with radiometals. Herein we describe the synthesis of the unlabeled standard of this prosthetic moiety, its protected tin precursor, and radioiodinated SIB-DOTA. An anti-EGFRvIII-reactive mAb, L8A4 was radiolabeled with [(131)I]SIB-DOTA in 27.1±6.2% (n=2) conjugation yields and its targeting properties to the same mAb labeled with [(125)I]SGMIB both in vitro and in vivo using U87MG·ΔEGFR cells and xenografts were compared. In vitro paired-label internalization assays showed that the intracellular radioactivity from [(131)I]SIB-DOTA-L8A4 was 21.4±0.5% and 26.2±1.1% of initially bound radioactivity at 16 and 24h, respectively. In comparison, these values for [(125)I]SGMIB-L8A4 were 16.7±0.5% and 14.9±1.1%. Similarly, the SIB-DOTA prosthetic group provided better tumor targeting in vivo than SGMIB over 8 d period. These results suggest that SIB-DOTA warrants further evaluation as a residualizing agent for labeling internalizing mAbs including those targeted to EGFRvIII.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Tin, shot, 99.999% trace metals basis
Sigma-Aldrich
Tin, foil, thickness 0.5 mm, 99.998% trace metals basis
Sigma-Aldrich
Tin, powder, <45 μm particle size, 99.8% trace metals basis
Sigma-Aldrich
Tin, wire, diam. 0.5 mm, 99.999% trace metals basis
Sigma-Aldrich
Tin, 99.8%, shot, 3 mm
Sigma-Aldrich
Tin, powder, -100 mesh, 99.99% trace metals basis
Supelco
Tin (impurities), manufactured by MBH Analytical Ltd (71X SR0)
Sigma-Aldrich
Tin, nanopowder, <150 nm particle size (SEM), ≥99% trace metals basis
Sigma-Aldrich
Tin, foil, thickness 0.127 mm, 99.9%
Sigma-Aldrich
Tin, granular, 0.425-2.0 mm particle size, ≥99.5%, ACS reagent
Sigma-Aldrich
Tin, ≥99%, powder
Sigma-Aldrich
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, ≥97.0% (CHN)
Sigma-Aldrich
Tin, powder, <150 μm, 99.5% trace metals basis
Sigma-Aldrich
Tin, powder, 10 μm, 99% trace metals basis